Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Embecta Corp. stock logo
EMBC
Embecta
$10.15
-0.8%
$12.28
$9.93
$32.00
$584.43M0.86384,971 shs446,240 shs
Iradimed Corporation stock logo
IRMD
Iradimed
$44.70
+1.9%
$42.62
$36.12
$51.04
$566.08M0.8643,567 shs62,939 shs
Nevro Corp. stock logo
NVRO
Nevro
$11.29
+1.3%
$13.37
$10.27
$28.89
$414.13M0.96545,345 shs373,702 shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$13.60
+2.7%
$13.62
$9.57
$21.60
$508.74M1.06288,403 shs760,549 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Embecta Corp. stock logo
EMBC
Embecta
0.00%-1.55%-20.58%-40.61%-65.06%
Iradimed Corporation stock logo
IRMD
Iradimed
0.00%+6.78%+8.39%+0.09%+3.59%
Nevro Corp. stock logo
NVRO
Nevro
0.00%-0.27%-14.53%-30.57%-59.06%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.00%+4.70%-4.16%-3.61%-26.37%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Embecta Corp. stock logo
EMBC
Embecta
3.9236 of 5 stars
2.84.03.30.01.73.31.9
Iradimed Corporation stock logo
IRMD
Iradimed
4.9959 of 5 stars
3.54.02.54.43.13.33.1
Nevro Corp. stock logo
NVRO
Nevro
1.6959 of 5 stars
4.02.00.00.00.01.70.6
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.5952 of 5 stars
2.01.00.00.01.51.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Embecta Corp. stock logo
EMBC
Embecta
1.50
Reduce$16.0057.64% Upside
Iradimed Corporation stock logo
IRMD
Iradimed
3.00
Buy$62.5039.82% Upside
Nevro Corp. stock logo
NVRO
Nevro
2.00
Hold$21.2388.05% Upside
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.00
Hold$15.5013.97% Upside

Current Analyst Ratings

Latest IRMD, OFIX, NVRO, and EMBC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
4/22/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$65.00
4/22/2024
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
4/15/2024
Nevro Corp. stock logo
NVRO
Nevro
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$18.00 ➝ $16.00
4/11/2024
Nevro Corp. stock logo
NVRO
Nevro
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$20.00 ➝ $16.00
4/8/2024
Nevro Corp. stock logo
NVRO
Nevro
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $14.00
4/3/2024
Nevro Corp. stock logo
NVRO
Nevro
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $16.00
4/1/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Singular Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
3/7/2024
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$12.00 ➝ $15.00
2/22/2024
Nevro Corp. stock logo
NVRO
Nevro
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$23.00 ➝ $19.00
2/22/2024
Nevro Corp. stock logo
NVRO
Nevro
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$20.00 ➝ $17.00
(Data available from 5/5/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Embecta Corp. stock logo
EMBC
Embecta
$1.12B0.52$3.69 per share2.75($14.34) per share-0.71
Iradimed Corporation stock logo
IRMD
Iradimed
$65.56M8.63$1.42 per share31.39$5.66 per share7.90
Nevro Corp. stock logo
NVRO
Nevro
$425.17M0.97N/AN/A$8.10 per share1.39
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$746.64M0.68N/AN/A$16.11 per share0.84

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Embecta Corp. stock logo
EMBC
Embecta
$70.40M$0.9510.684.59N/A4.93%-18.66%12.38%5/9/2024 (Confirmed)
Iradimed Corporation stock logo
IRMD
Iradimed
$17.19M$1.4131.7025.99N/A26.48%25.01%20.60%8/1/2024 (Estimated)
Nevro Corp. stock logo
NVRO
Nevro
-$92.21M-$2.57N/AN/AN/A-21.69%-30.22%-15.17%5/7/2024 (Confirmed)
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$151.40M-$4.14N/AN/AN/A-20.28%-10.63%-7.34%5/7/2024 (Confirmed)

Latest IRMD, OFIX, NVRO, and EMBC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Embecta Corp. stock logo
EMBC
Embecta
$0.43N/A-$0.43N/AN/AN/A  
5/7/2024N/A
Nevro Corp. stock logo
NVRO
Nevro
-$1.02N/A+$1.02N/AN/AN/A  
5/7/2024N/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$0.32N/A+$0.32N/AN/AN/A  
3/5/2024Q4 2023
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$0.60-$0.59+$0.01-$0.59N/A$200.42 million    
2/21/2024Q4 2023
Nevro Corp. stock logo
NVRO
Nevro
-$0.50-$0.15+$0.35-$0.05$115.93 million$116.18 million
2/9/202412/31/2023
Embecta Corp. stock logo
EMBC
Embecta
$0.46$0.61+$0.15$0.85$264.92 million$277.30 million      
2/8/2024Q4 2023
Iradimed Corporation stock logo
IRMD
Iradimed
$0.37$0.36-$0.01$0.36N/A$17.45 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Embecta Corp. stock logo
EMBC
Embecta
$0.605.91%N/A63.16%N/A
Iradimed Corporation stock logo
IRMD
Iradimed
$0.601.34%N/A42.55%N/A
Nevro Corp. stock logo
NVRO
Nevro
N/AN/AN/AN/AN/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
N/AN/AN/AN/AN/A

Latest IRMD, OFIX, NVRO, and EMBC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Quarterly$0.151.37%5/17/20245/20/20245/30/2024
2/9/2024
Embecta Corp. stock logo
EMBC
Embecta
Quarterly$0.153.69%2/27/20242/28/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.20
1.75
Iradimed Corporation stock logo
IRMD
Iradimed
N/A
4.65
3.87
Nevro Corp. stock logo
NVRO
Nevro
0.72
6.37
4.94
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.19
2.54
1.20

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Embecta Corp. stock logo
EMBC
Embecta
93.83%
Iradimed Corporation stock logo
IRMD
Iradimed
92.34%
Nevro Corp. stock logo
NVRO
Nevro
95.52%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
89.76%

Insider Ownership

CompanyInsider Ownership
Embecta Corp. stock logo
EMBC
Embecta
0.28%
Iradimed Corporation stock logo
IRMD
Iradimed
42.60%
Nevro Corp. stock logo
NVRO
Nevro
3.20%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
4.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Embecta Corp. stock logo
EMBC
Embecta
2,20057.58 million57.42 millionOptionable
Iradimed Corporation stock logo
IRMD
Iradimed
14812.66 million7.27 millionOptionable
Nevro Corp. stock logo
NVRO
Nevro
1,21536.68 million35.51 millionOptionable
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1,63437.41 million35.65 millionOptionable

IRMD, OFIX, NVRO, and EMBC Headlines

SourceHeadline
Orthofix Medical (OFIX) to Release Earnings on TuesdayOrthofix Medical (OFIX) to Release Earnings on Tuesday
americanbankingnews.com - May 5 at 5:40 AM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the FirmSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 30 at 9:10 PM
3 Orthofix Execs Fired for Offensive Conduct Claim Wrongful Termination, Demand Severance3 Orthofix Execs Fired for 'Offensive Conduct' Claim Wrongful Termination, Demand Severance
law.com - April 30 at 7:42 PM
Orthofix Medical (OFIX) Set to Announce Earnings on TuesdayOrthofix Medical (OFIX) Set to Announce Earnings on Tuesday
marketbeat.com - April 30 at 11:09 AM
OssDsign signs contract with 100 VA orthopedic hospitalsOssDsign signs contract with 100 VA orthopedic hospitals
beckersspine.com - April 30 at 7:47 AM
Pyx Health adds legal chiefPyx Health adds legal chief
complianceweek.com - April 27 at 8:39 PM
Orthofix names chief legal officerOrthofix names chief legal officer
complianceweek.com - April 26 at 7:19 PM
Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist InvestorsMarriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors
msn.com - April 26 at 7:37 AM
Chief executive shakeups: 8 moves in 100 daysChief executive shakeups: 8 moves in 100 days
beckersspine.com - April 23 at 5:20 PM
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
businesswire.com - April 23 at 7:00 AM
Sacroiliac Joint Fusion Market To Reach USD 4,106.7 Billion By 2032 | DataHorizzon ResearchSacroiliac Joint Fusion Market To Reach USD 4,106.7 Billion By 2032 | DataHorizzon Research
finance.yahoo.com - April 22 at 2:09 PM
Stryker’s Resilience Amidst Competitive Pressures Reinforces Buy RatingStryker’s Resilience Amidst Competitive Pressures Reinforces Buy Rating
markets.businessinsider.com - April 22 at 2:09 PM
Orthofix (OFIX) Gets a Hold from JMP SecuritiesOrthofix (OFIX) Gets a Hold from JMP Securities
markets.businessinsider.com - April 19 at 8:46 PM
Lost Money on Orthofix Medical Inc. (OFIX)? You May Have Been Affected by Fraud - Contact Levi & KorsinskyLost Money on Orthofix Medical Inc. (OFIX)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
accesswire.com - April 19 at 7:30 AM
Orthofix Medical Inc. (OFIX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsOrthofix Medical Inc. (OFIX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
accesswire.com - April 18 at 7:25 AM
OTC Braces and Supports Market Outlook, Size, Prominent Players, Share, Revenue, and Forecast 2024 to 2032OTC Braces and Supports Market Outlook, Size, Prominent Players, Share, Revenue, and Forecast 2024 to 2032
taiwannews.com.tw - April 18 at 1:11 AM
Orthofix replaces fired CLO, grapples with internal control ‘material weakness’Orthofix replaces fired CLO, grapples with internal control ‘material weakness’
cfodive.com - April 17 at 8:11 PM
6 medtech notes: Orthofix, Centinel Spine and more6 medtech notes: Orthofix, Centinel Spine and more
beckersspine.com - April 17 at 3:10 PM
Orthofix Replaces Legal Chief Fired for Offensive ConductOrthofix Replaces Legal Chief Fired for 'Offensive Conduct'
law.com - April 16 at 7:07 PM
The future of disc replacementsThe future of disc replacements
beckersspine.com - April 16 at 2:07 PM
Orthofix names Andres Cedron as chief legal officerOrthofix names Andres Cedron as chief legal officer
massdevice.com - April 16 at 9:06 AM
Orthofix Names Andres Cedron as New Chief Legal OfficerOrthofix Names Andres Cedron as New Chief Legal Officer
finance.yahoo.com - April 16 at 9:06 AM
ATTENTION Orthofix Medical Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your RightsATTENTION Orthofix Medical Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
accesswire.com - April 12 at 7:30 AM
Orthofix Medical Inc. (NASDAQ:OFIX) Shares Bought by Vanguard Group Inc.Orthofix Medical Inc. (NASDAQ:OFIX) Shares Bought by Vanguard Group Inc.
marketbeat.com - April 12 at 4:08 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Embecta logo

Embecta

NASDAQ:EMBC
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Iradimed logo

Iradimed

NASDAQ:IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Nevro logo

Nevro

NYSE:NVRO
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Orthofix Medical logo

Orthofix Medical

NASDAQ:OFIX
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.